全文获取类型
收费全文 | 6590篇 |
免费 | 864篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 172篇 |
妇产科学 | 90篇 |
基础医学 | 857篇 |
口腔科学 | 157篇 |
临床医学 | 732篇 |
内科学 | 1515篇 |
皮肤病学 | 59篇 |
神经病学 | 487篇 |
特种医学 | 584篇 |
外科学 | 947篇 |
综合类 | 133篇 |
一般理论 | 2篇 |
预防医学 | 702篇 |
眼科学 | 59篇 |
药学 | 544篇 |
中国医学 | 7篇 |
肿瘤学 | 395篇 |
出版年
2021年 | 99篇 |
2020年 | 50篇 |
2019年 | 80篇 |
2018年 | 118篇 |
2017年 | 91篇 |
2016年 | 116篇 |
2015年 | 106篇 |
2014年 | 154篇 |
2013年 | 194篇 |
2012年 | 262篇 |
2011年 | 308篇 |
2010年 | 201篇 |
2009年 | 197篇 |
2008年 | 245篇 |
2007年 | 252篇 |
2006年 | 281篇 |
2005年 | 245篇 |
2004年 | 255篇 |
2003年 | 237篇 |
2002年 | 245篇 |
2001年 | 200篇 |
2000年 | 224篇 |
1999年 | 185篇 |
1998年 | 132篇 |
1997年 | 110篇 |
1996年 | 121篇 |
1995年 | 113篇 |
1994年 | 95篇 |
1993年 | 100篇 |
1992年 | 133篇 |
1991年 | 120篇 |
1990年 | 123篇 |
1989年 | 155篇 |
1988年 | 138篇 |
1987年 | 150篇 |
1986年 | 152篇 |
1985年 | 127篇 |
1984年 | 120篇 |
1983年 | 91篇 |
1982年 | 79篇 |
1981年 | 81篇 |
1980年 | 53篇 |
1979年 | 79篇 |
1978年 | 50篇 |
1977年 | 65篇 |
1976年 | 47篇 |
1975年 | 50篇 |
1974年 | 54篇 |
1972年 | 62篇 |
1970年 | 53篇 |
排序方式: 共有7470条查询结果,搜索用时 31 毫秒
31.
32.
Therapeutic response in patients with advanced breast cancer is conventionally assessed with reference to criteria devised by the International Union Against Cancer. Evidence to date suggests, however, that assessments of equivalent quality may be obtained at lower cost from the use of serum markers. The paper presents estimates of potential cost savings resulting from the use of serum markers in place of conventional assessment and argues that the size of these savings merits the establishment of a randomised controlled trial. 相似文献
33.
34.
35.
We have retrospectively assessed the computed tomography (CT) findings in 92 patients suffering severe blunt abdominal trauma. Surgical findings and clinical follow-up were correlated with the CT findings. In nine patients CT was first used after emergency surgery and provided baseline data which was useful for further management. In two patients CT did not demonstrate small hepatic lacerations seen during previous surgery. No deaths were recorded. In 16 patients surgery followed CT within 24 h; there was good correlation between the CT and operative findings in 10 patients. However, CT failed to detect significant solid organ injury in five patients and was misleading (false positive) in another patient. There were two deaths amongst these 16 patients. Sixty-seven haemodynamically stable patients were initially managed non-operatively. Fifteen of these 67 patients had normal CT examinations; only one had subsequent laparotomy (for reasons unconnected with the trauma) where no injury was detected; there were no deaths. Of the 52 patients with an abnormal CT examination, 43 were successfully managed non-operatively. There were three deaths, including one where an injury missed at CT contributed to the demise of the patient. After an initial trial of non-operative management, the remaining six patients went to surgery where there was good concordance with the CT findings except for one missed renal injury. Active non-operative management of blunt abdominal trauma is widely accepted in haemodynamically stable patients and this report shows how CT supports this policy of surgical restraint in such cases. However, on review CT missed 13 injuries in nine patients overall; stricter attention to technique and better equipment may lead to improved results in the future. 相似文献
36.
37.
Alex W Wilson Stephen J Medhurst Claire I Dixon Nick C Bontoft Lisa A Winyard Kim T Brackenborough Jorge De Alba Christopher J Clarke Martin J Gunthorpe Gareth A Hicks Chas Bountra Daniel S McQueen Iain P Chessell 《European Journal of Pain》2006,10(6):537-549
Clinically, inflammatory pain is far more persistent than that typically modelled pre-clinically, with the majority of animal models focussing on short-term effects of the inflammatory pain response. The large attrition rate of compounds in the clinic which show pre-clinical efficacy suggests the need for novel models of, or approaches to, chronic inflammatory pain if novel mechanisms are to make it to the market. A model in which a more chronic inflammatory hypersensitivity phenotype is profiled may allow for a more clinically predictive tool. The aims of these studies were to characterise and validate a chronic model of inflammatory pain. We have shown that injection of a large volume of adjuvant to the intra-articular space of the rat knee results in a prolonged inflammatory pain response, compared to the response in an acute adjuvant model. Additionally, this model also results in a hypersensitive state in the presence and absence of inflammation. A range of clinically effective analgesics demonstrate activity in this chronic model, including morphine (3mg/kg, t.i.d.), dexamethasone (1mg/kg, b.i.d.), ibuprofen (30mg/kg, t.i.d.), etoricoxib (5mg/kg, b.i.d.) and rofecoxib (0.3-10mg/kg, b.i.d.). A further aim was to exemplify the utility of this chronic model over the more acute intra-plantar adjuvant model using two novel therapeutic approaches; NR2B selective NMDA receptor antagonism and iNOS inhibition. Our data shows that different effects were observed with these therapies when comparing the acute model with the model of chronic inflammatory joint pain. These data suggest that the chronic model may be more relevant to identifying mechanisms for the treatment of chronic inflammatory pain states in the clinic. 相似文献
38.
39.
S L Stern K N Dixon R A Sansone M D Lake E Nemzer D Jones 《Comprehensive psychiatry》1992,33(3):207-212
We assessed the lifetime prevalence and morbid risk of psychoactive substance use disorder (SUD; alcoholism and drug use disorder) in the first- and second-degree relatives, excluding children, of 34 female patients with anorexia nervosa (AN) and 34 age- and sex-matched controls who had no history of an eating disorder. Diagnoses of relatives were made blind to probands' diagnoses. The prevalence of SUD was 9% in both anorectic and control relatives, and the figures for morbid risk were 14% and 15%, respectively; these differences were nonsignificant. These results suggest that adolescent and adult women with AN do not possess many of the familial factors that predispose to the development of psychoactive SUD. 相似文献
40.
R Dixon AM Hughes K Nairn M Sellers JV Kemp RA Yates 《Cephalalgia : an international journal of headache》1998,18(7):468-475
Zolmitriptan (ZomigTM ) is a 5HT1B/1D agonist which has the ability to cross the intact blood-brain barrier to access central as well as peripheral receptors. Because of the potential for central nervous system side effects, this randomized, double-blind, placebo-controlled, 6-period crossover study evaluated the effects of 2.5 and 5 mg doses of zolmitriptan on psychomotor performance and investigated any pharmacodynamic or pharmacokinetic interaction with diazepam. Twelve healthy volunteers received the following "treatments" as single doses: zolmitriptan 2.5 mg, zolmitriptan 5 mg, diazepam 10 mg, zolmitriptan 2.5 mg+diazepam 10 mg, zolmitriptan 5 mg+diazepam 10 mg and placebo. Pre-dose and at 1, 4, 8, and 24 h post-dose, the following validated battery of psychomotor tests was performed: Bond-Lader visual analogue scales (calmness, contentedness, and alertness factors), critical flicker fusion test, choice reaction time (recognition, motor, and total reaction times), finger-tapping test, number cancellation test and digit symbol substitution test. Plasma concentrations of zolmitriptan, its active metabolite, and diazepam and its active metabolites were measured at the same timepoints. Zolmitriptan 2.5 and 5 mg had no effect on psychomotor function when given alone. In contrast, diazepam 10 mg had profound effects, consistent with its sedative properties, but there was no synergism on concomitant administration of either dose of zolmitriptan. Plasma concentrations of zolmitriptan, diazepam, and their respective active metabolites were similar when the two drugs were given alone or in combination. 相似文献